Key result
Serum extracellular vesicles from ASFV-infected pigs contained specific viral proteins and differentially expressed swine proteins (56 in Benin group, 7 in OURT 88/3 group) compared to controls.
Why the study?
African swine fever lacks an effective commercial treatment or vaccine, prompting investigation into extracellular vesicles as a potential novel vaccination platform.
Serum extracellular vesicles from ASFV-infected pigs contain specific viral and host proteins, particularly those related to coagulation cascades, which may contribute to understanding ASFV pathogenesis.
) of all breeds and ages, with a high lethality of up to 90-100% in naïve animals. The causative agent, African swine fever virus (ASFV), is a large and complex double-stranded DNA arbovirus which is currently spreading worldwide, with serious socioeconomic consequences. There is no treatment or effective vaccine commercially available, and most of the current research is focused on attenuated viral models, with limited success so far. Thus, new strategies are under investigation. Extracellular vesicles (EVs) have proven to be a promising new vaccination platform for veterinary diseases in situations in which conventional approaches have not been completely successful. Here, serum extracellular vesicles from infected pigs using two different ASFV viruses (OURT 88/3 and Benin ΔMGF), corresponding to a naturally attenuated virus and a deletion mutant, respectively, were characterized in order to determine possible differences in the content of swine and viral proteins in EV-enriched fractions. Firstly, EVs were characterized by their CD5, CD63, CD81 and CD163 surface expression. Secondly, ASFV proteins were detected on the surface of EVs from ASFV-infected pig serum. Finally, proteomic analysis revealed few specific proteins from ASFV in the EVs, but 942 swine proteins were detected in all EV preparations (negative controls, and OURT 88/3 and Benin ΔMGF-infected preparations). However, in samples from OURT 88/3-infected animals, only a small number of proteins were differentially identified compared to control uninfected animals. Fifty-six swine proteins (Group Benin) and seven proteins (Group OURT 88/3) were differentially detected on EVs when compared to the EV control group. Most of these were related to coagulation cascades. The results presented here could contribute to a better understanding of ASFV pathogenesis and immune/protective responses in the host.
No takes yet. Share an insight, caveat, or question.
Montaner-Tarbés et al. (2019) studied African swine fever virus (ASFV) infection. ASFV infection (OURT 88/3 and Benin ΔMGF) vs. Uninfected control animals was evaluated on Protein content of serum extracellular vesicles. Serum extracellular vesicles from ASFV-infected pigs contained specific viral proteins and differentially expressed swine proteins (56 in Benin group, 7 in OURT 88/3 group) compared to controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: